How Opioid Pain Drugs Affect Sleep and Mood in Cancer Patients
Part of Pain clinical trials.
This study examines how opioid medications (strong pain relievers) impact sleep quality and emotional well-being in cancer patients with moderate to severe pain. Researchers will track your sleep patterns and mood to better understand these side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer diagnosis and moderate to severe cancer pain (rated 4 or higher on a pain scale)
- You are between 18 and 75 years old
- You have been taking a stable dose of opioid pain medication for at least one week with good pain control
- You can complete questionnaires and wear a sleep-tracking wristband during the study
- You have adequate liver and kidney function and are expected to live at least 3 months
- You have no history of opioid, alcohol, or drug abuse
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well patients sleep and how much pain they feel after video-assisted thoracoscopic surgery for lung cancer. It aims to help doctors better manage your recovery.
This trial tests a sustained-release tablet (oxycodone/naloxone) for cancer patients with severe pain and constipation caused by opioids. It aims to see how well the drug works in real-world conditions.
This study tests whether cannabis oil (with or without CBD) can help cancer patients sleep better than a placebo. You'll take the medication at home and wear a sleep monitor to track how well it works.
This study tests a sleep improvement program to help people with chronic widespread pain reduce or stop their opioid pain medication. If you want to cut back on opioids and have trouble sleeping, this treatment might be a good fit.
This study looks at pain and sleep problems in children ages 6 to 12 who have finished cancer treatment, to understand how they recover and to help improve their care.
This Phase 2 study tests a new medicine (3D1002) taken together with extended-release oxycodone to improve moderate to severe cancer pain. You may be considered if your cancer pain is stable and you can follow the study’s strict pain-medication rules.
Hear when a new Moderate to Severe Cancer Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.